Mackenzie Financial’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-62,964	Closed	-$54.1K	–	1625
2023 Q4	$54.1K	Buy	62,964 +18,084	+40%	+$15.5K	﹤0.01%	1443
2023 Q3	$53.9K	Buy	44,880 +25,788	+135%	+$30.9K	﹤0.01%	1407
2023 Q2	$51.5K	Buy	19,092 +6,309	+49%	+$17K	﹤0.01%	1456
2023 Q1	$52.2K	Buy	+12,783	New	+$52.2K	﹤0.01%	1440